{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:59:24Z","timestamp":1794895164093,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) can be produced from aflatoxin B1 (AFB1) administration. Although berberine (BER) acts as an anticancer agent and can counteract the AFB1 effect, it has low bioavailability. Nanotechnology can overcome this problem. This research aimed to synthesize berberine nanoparticles (NPs) and then estimate their therapeutic effect compared to that of berberine against aflatoxin-induced hepatotoxicity. The desolvation method was used to prepare BER\u2013NPs. Aflatoxicosis was induced by 5 consecutive intraperitoneal injections (IP) of 200 \u00b5g\/kg\/day AFB dissolved in dimethylsulfoxide (DMSO). After the induction period, two treatments were performed: the first with 100\u00a0mg\/kg BER and the second with 10\u00a0mg\/kg BER-NPs. Liver, kidney, and diabetic profiles were estimated by using standardized methods. Hepatic oxidative stress, inflammatory, cancer cell proliferation, and invasion markers were used by ELISA and qPCR techniques. The TEM image shows that both BSA NPs and BER-BSA NPs had spherical, regular, and uniform shapes. The BER encapsulation efficiency % was 78.5. The formed-BER-BSA NPs showed a loading capacity % of 7.71 and the synthesis yield % of 92.6. AFB1 increases pro-oxidant markers, decreases antioxidant systems, stimulates inflammatory enzymes, inhibits anti-inflammatory markers, decreases tumor suppressor enzymes, increases oncogenes, increases glycolytic activity, prevents cell death, and promotes cell growth. Most of the biochemical markers and hepatic architecture were normalized in the BER-BSA NP-treated group but not in the BER-treated group. Altogether, the obtained data proved that treatment with BER-NPs was more efficient than treatment with berberine against aflatoxicoses induced in rats.<\/jats:p>","DOI":"10.1186\/s40360-023-00683-w","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T23:24:03Z","timestamp":1691623443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia"],"prefix":"10.1186","volume":"24","author":[{"given":"Sarah M.","family":"Khedr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-4377","authenticated-orcid":false,"given":"Doaa A.","family":"Ghareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadia A.","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germine M.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"issue":"6","key":"683_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"683_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43046-020-0016-x","volume":"32","author":"WM Rashed","year":"2020","unstructured":"Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: a comprehensive overview. J Egypt Natl Canc Inst. 2020;32(1):1\u201311.","journal-title":"J Egypt Natl Canc Inst"},{"key":"683_CR3","doi-asserted-by":"crossref","unstructured":"Swetha C & Girish BP. An overview on aflatoxin B1 induced initiation and progression of hepatocellular carcinoma. Ther Prec Med Manag Hepatocell Carcinoma, 2022:73\u201379","DOI":"10.1016\/B978-0-323-98806-3.00016-7"},{"key":"683_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2019.113317","volume":"255","author":"W Huang","year":"2019","unstructured":"Huang W, Cao Z, Zhang J, Ji Q, Li Y. Aflatoxin B1 promotes autophagy associated with oxidative stress-related PI3K\/AKT\/mTOR signaling pathway in mice testis. Environ Pollut. 2019;255: 113317.","journal-title":"Environ Pollut"},{"issue":"1","key":"683_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40659-019-0243-6","volume":"52","author":"L Liu","year":"2019","unstructured":"Liu L, Fan J, Ai G, Liu J, Luo N, Li C, Cheng Z. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol Res. 2019;52(1):1\u201314.","journal-title":"Biol Res"},{"key":"683_CR6","doi-asserted-by":"crossref","unstructured":"Ghareeb DA, Saleh SR, Seadawy MG, Nofal MS, Abdulmalek SA, Hassan SF., ... & El Demellawy MA. Nanoparticles of ZnO\/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity. J Pharm Investig. 2021;51(6):735\u2013757.","DOI":"10.1007\/s40005-021-00544-w"},{"key":"683_CR7","doi-asserted-by":"crossref","unstructured":"Song, L., Luo, Y., Wang, X., Almutairi, M. M., Pan, H., Li, W., ... & Hong, M.. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation. Mol Med Rep. 2019;20(5):4654\u20134664.","DOI":"10.3892\/mmr.2019.10698"},{"issue":"4","key":"683_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/biomedicines8040090","volume":"8","author":"S Habtemariam","year":"2020","unstructured":"Habtemariam S. The quest to enhance the efficacy of berberine for type-2 diabetes and associated diseases: physicochemical modification approaches. Biomedicines. 2020;8(4):90.","journal-title":"Biomedicines"},{"key":"683_CR9","doi-asserted-by":"crossref","unstructured":"Javed Iqbal M, Quispe C, Javed Z, Sadia H, Qadri QR, Raza S., ... & Sharifi-Rad J. Nanotechnology-based strategies for berberine delivery system in cancer treatment: Pulling strings to keep berberine in power. Front Mol Biosci. 2021;7:624494","DOI":"10.3389\/fmolb.2020.624494"},{"key":"683_CR10","volume-title":"What is nanotechnology and why does it matter?: from science to ethics","author":"P Lin","year":"2009","unstructured":"Lin P, Moore D, Allhoff F. What is nanotechnology and why does it matter?: from science to ethics. John Wiley & Sons; 2009."},{"key":"683_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/NSA.S117018","volume":"10","author":"ES Bronze-Uhle","year":"2017","unstructured":"Bronze-Uhle ES, Costa BC, Ximenes VF, Lisboa-Filho PN. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl. 2017;10:11.","journal-title":"Nanotechnol Sci Appl"},{"issue":"8","key":"683_CR12","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.7314\/APJCP.2015.16.8.3371","volume":"16","author":"N Suwannakul","year":"2015","unstructured":"Suwannakul N, Punvittayagul C, Jarukamjorn K, Wongpoomchai R. Purple rice bran extract attenuates the aflatoxin B1-induced initiation stage of hepatocarcinogenesis by alteration of xenobiotic metabolizing enzymes. Asian Pac J Cancer Prev. 2015;16(8):3371\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"683_CR13","doi-asserted-by":"crossref","unstructured":"Ghareeb DA, Khalil S, Hafez HS, Bajorath J, Ahmed HE, Sarhan E., ... & El-Demellawy MA. Berberine reduces neurotoxicity related to nonalcoholic steatohepatitis in rats. Evid Based Complement Altern Med. 2015;2015.","DOI":"10.1155\/2015\/361847"},{"issue":"2","key":"683_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","volume":"1","author":"S Parasuraman","year":"2010","unstructured":"Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010;1(2):87\u201393.","journal-title":"J Pharmacol Pharmacother"},{"key":"683_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.freeradbiomed.2015.08.030","volume":"89","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wang K, Lei Y, Li Q, Nice EC, Huang C. Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response. Free Radical Biol Med. 2015;89:452\u201365.","journal-title":"Free Radical Biol Med"},{"issue":"2","key":"683_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0003-9861(59)90258-9","volume":"80","author":"AL Tappel","year":"1959","unstructured":"Tappel AL, Zalkin H. Lipide peroxidation in isolated mitochondria. Arch Biochem Biophys. 1959;80(2):326\u201332.","journal-title":"Arch Biochem Biophys"},{"key":"683_CR17","first-page":"414","volume":"86","author":"HAC Montgomery","year":"1961","unstructured":"Montgomery HAC, Dymock JF. Nitric oxide assay. Analyst. 1961;86:414.","journal-title":"Analyst"},{"key":"683_CR18","doi-asserted-by":"crossref","unstructured":"Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacol. 1974;11(3):151\u2013169.","DOI":"10.1159\/000136485"},{"key":"683_CR19","doi-asserted-by":"crossref","unstructured":"Aebi, H. [13] Catalase in vitro. In Methods in enzymology. 1984;105:121\u2013126. Academic press.\u200f","DOI":"10.1016\/S0076-6879(84)05016-3"},{"key":"683_CR20","doi-asserted-by":"crossref","unstructured":"C. H, A., & Ravindran, A. BSA nanoparticle loaded atorvastatin calcium-a new facet for an old drug. PloS one. 2014;9(2):e86317.","DOI":"10.1371\/journal.pone.0086317"},{"key":"683_CR21","doi-asserted-by":"publisher","unstructured":"Solanki R, Patel K & Patel S. Bovine serum albumin nanoparticles for the efficient delivery of berberine: Preparation, characterization and in vitro biological studies. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021;608:125501. https:\/\/doi.org\/10.1016\/j.colsurfa.2020.125501.","DOI":"10.1016\/j.colsurfa.2020.125501"},{"key":"683_CR22","doi-asserted-by":"crossref","unstructured":"Imam SS, Alshehri S, Ghoneim MM, Zafar A, Alsaidan OA, mAlruwaili NK., ... & Rizwanullah M. Recent advancement in chitosan-based nanoparticles for improved oral bioavailability and bioactivity of phytochemicals: Challenges and perspectives. Polymers. 202113(22):4036.","DOI":"10.3390\/polym13224036"},{"key":"683_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijbiomac.2018.04.043","volume":"115","author":"M Salehiabar","year":"2018","unstructured":"Salehiabar M, Nosrati H, Javani E, Aliakbarzadeh F, Manjili HK, Davaran S, Danafar H. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Int J Biol Macromol. 2018;115:83\u20139.","journal-title":"Int J Biol Macromol"},{"key":"683_CR24","doi-asserted-by":"crossref","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS., ... & Shin HS. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):1\u201333.","DOI":"10.1186\/s12951-018-0392-8"},{"issue":"W1","key":"683_CR25","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015;43(W1):W566\u201370.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"683_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/17458080.2015.1104925","volume":"11","author":"F Jing","year":"2016","unstructured":"Jing F, Xu W, Liu D, Wang C, Sui Z. Enhanced antithrombotic effect of hirudin by bovine serum albumin nanoparticles. J Exp Nanosci. 2016;11(8):619\u201329.","journal-title":"J Exp Nanosci"},{"key":"683_CR27","doi-asserted-by":"crossref","unstructured":"Xu Q, Shi W, Lv P, Meng W, Mao G, Gong C., ... & Xiao K. Critical role of caveolin-1 in aflatoxin B1-induced hepatotoxicity via the regulation of oxidation and autophagy. Cell Death Dis. 2020;11(1);1\u201316.","DOI":"10.1038\/s41419-019-2197-6"},{"key":"683_CR28","doi-asserted-by":"crossref","unstructured":"Gao X, Xu J, Jiang L, Liu W, Hong H, Qian Y., ... & Wei Z. Morin alleviates aflatoxin B1-induced liver and kidney injury by inhibiting heterophil extracellular traps release, oxidative stress and inflammatory responses in chicks. Poultry Sci. 2021;100(12):101513","DOI":"10.1016\/j.psj.2021.101513"},{"issue":"6","key":"683_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/toxins13060401","volume":"13","author":"J Ma","year":"2021","unstructured":"Ma J, Liu Y, Guo Y, Ma Q, Ji C, Zhao L. Transcriptional profiling of aflatoxin B1-induced oxidative stress and inflammatory response in macrophages. Toxins. 2021;13(6):401.","journal-title":"Toxins"},{"issue":"3","key":"683_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/01635581.2018.1446091","volume":"70","author":"SJ Desai","year":"2018","unstructured":"Desai SJ, Prickril B, Rasooly A. Mechanisms of phytonutrient modulation of cyclooxygenase-2 (COX-2) and inflammation related to cancer. Nutr Cancer. 2018;70(3):350\u201375.","journal-title":"Nutr Cancer"},{"key":"683_CR31","doi-asserted-by":"crossref","unstructured":"You J, Chen W, Chen J, Zheng Q, Dong J & Zhu Y(). The oncogenic role of ARG1 in progression and metastasis of hepatocellular carcinoma. BioMed Res Int. 2018;2018.","DOI":"10.1155\/2018\/2109865"},{"issue":"34","key":"683_CR32","doi-asserted-by":"publisher","first-page":"57707","DOI":"10.18632\/oncotarget.17202","volume":"8","author":"L Liu","year":"2017","unstructured":"Liu L, Liao JZ, He XX, Li PY. The role of autophagy in hepatocellular carcinoma: friend or foe. Oncotarget. 2017;8(34):57707.","journal-title":"Oncotarget"},{"key":"683_CR33","doi-asserted-by":"crossref","unstructured":"Milella M, Falcone I, Conciatori F, Cesta Incani U, Del Curatolo A, Inzerilli N., ... & Ciuffreda L. PTEN: multiple functions in human malignant tumors. Front cOncol. 2015;5:24","DOI":"10.3389\/fonc.2015.00024"},{"issue":"5","key":"683_CR34","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/ijms19051308","volume":"19","author":"A Adamek","year":"2018","unstructured":"Adamek A, Kasprzak A. Insulin-like growth factor (IGF) system in liver diseases. Int J Mol Sci. 2018;19(5):1308.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"683_CR35","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.3390\/ijms20194915","volume":"20","author":"A Kasprzak","year":"2019","unstructured":"Kasprzak A, Adamek A. Insulin-like growth factor 2 (IGF2) signaling in colorectal cancer\u2014from basic research to potential clinical applications. Int J Mol Sci. 2019;20(19):4915.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"683_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/biom11020273","volume":"11","author":"C Mancarella","year":"2021","unstructured":"Mancarella C, Morrione A, Scotlandi K. Novel regulators of the IGF system in cancer. Biomolecules. 2021;11(2):273.","journal-title":"Biomolecules"},{"issue":"6","key":"683_CR37","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.7314\/APJCP.2014.15.6.2565","volume":"15","author":"J Lv","year":"2014","unstructured":"Lv J, Yu YQ, Li SQ, Luo L, Wang Q. Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1. Asian Pac J Cancer Prev. 2014;15(6):2565\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"key":"683_CR38","doi-asserted-by":"crossref","unstructured":"Ismail NF, Ghareeb DA, Hafez EL, EL-Saadani MA, El-Sayed MM & El Sewedy TS. Protective Effect of Cinnamon Zeylanicum, Berberis Vulgaris and Ulva Lactuca Extracts on Hepatocellular Toxicity Induced by Aspergillus Flavus Intake in Rats. Bull Egypt Soc Physiol Sci. 2022;38(2):111-122","DOI":"10.21608\/besps.2018.8158"},{"key":"683_CR39","first-page":"1","volume":"6","author":"P Malekinezhad","year":"2020","unstructured":"Malekinezhad P, Afzali N, Farhangfar SH, Omidi A, Mohammadi A. Berberine improves meat quality and carcass traits in broilers challenged with mycotoxins. Arch Med Lab Sci. 2020;6:1\u20139.","journal-title":"Arch Med Lab Sci"},{"key":"683_CR40","doi-asserted-by":"crossref","unstructured":"Yao Z., Wan Y, Li B, Zhai C, Yao F, Kang Y., ... & Lin D. Berberine induces mitochondrial-mediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCI-H2452 cells. Oncol Rep. 2018;40(6):3603\u20133610.","DOI":"10.3892\/or.2018.6757"},{"issue":"1","key":"683_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/13880209.2020.1865407","volume":"59","author":"G Li","year":"2021","unstructured":"Li G, Zhang C, Liang W, Zhang Y, Shen Y, Tian X. Berberine regulates the Notch1\/PTEN\/PI3K\/AKT\/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells. Pharm Biol. 2021;59(1):21\u201330.","journal-title":"Pharm Biol"},{"key":"683_CR42","doi-asserted-by":"crossref","unstructured":"Wang, Y., Tai, Y. L., Zhao, D., Zhang, Y., Yan, J., Kakiyama, G., ... & Zhou, H. Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways. Cells. 2021;10(2):210.","DOI":"10.3390\/cells10020210"},{"key":"683_CR43","doi-asserted-by":"crossref","unstructured":"Lam, P. L., Kok, S. L., Gambari, R., Kok, T. W., Leung, H. Y., Choi, K. L., ... & Chui, C. H. Evaluation of berberine\/bovine serum albumin nanoparticles for liver fibrosis therapy. Green Chem. 2015;17(3):1640\u20131646.","DOI":"10.1039\/C4GC01815J"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-023-00683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-023-00683-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-023-00683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:51:38Z","timestamp":1700477498000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-023-00683-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1186\/s40360-023-00683-w","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"3 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that all experiments were approved by the Faculty of Science, Alexandria University Pharmaceutical and Fermentation Industries Development Center, Scientific Research, and Technological Application City.In addition, all experimental procedures for animals were performed according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals approved by the Institutional Animal Care and Use Committees (IACUCs) of Pharmaceutical and Fermentation Industries Development Center, Scientific Research, and Technological Application City with approval number 21-1S-2220.Finally, we declare that all experiments were performed according to ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}